检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:尚方剑 陈波[2] SHANG Fangjian;CHEN Bo(Department of Breast Surgery,the Fourth Affiliated Hospital of China Medical University,Shenyang 110031,China;Department of Breast Surgery,the First Hospital of China Medical University,Shenyang 110000,China)
机构地区:[1]中国医科大学附属第四医院乳腺外科,辽宁沈阳110031 [2]中国医科大学附属第一医院乳腺外科,辽宁沈阳110000
出 处:《中国肿瘤外科杂志》2021年第6期541-545,共5页Chinese Journal of Surgical Oncology
摘 要:近年来,乳腺癌前哨淋巴结活检在临床中应用越来越广泛,但在前哨淋巴结阳性后续治疗的选择,新辅助化疗后前哨淋巴结活检的应用上还存在一定争议。总体来说,外科手术的减法仍是乳腺癌腋窝处理的趋势。文章结合最新研究进展就前哨淋巴结的热点问题做一论述,通过梳理目前前哨淋巴结应用方面的问题,为临床乳腺癌治疗策略的制定提供依据。In recent years,sentinel lymph node biopsy of breast cancer is widely used in clinical practice.However,there is still some controversy about the choice of sentinel lymph node positive follow-up treatment and the application of sentinel lymph node biopsy after neoadjuvant chemotherapy.Overall,surgical subtraction is still the trend of axillary treatment.The current hot issues involving sentinel lymph nodes will be reviewed in this article to provide reference for the treatment strategies in clinical practice.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222